vs
Ascendis Pharma A/S（ASND）与BOSTON BEER CO INC（SAM）财务数据对比。点击上方公司名可切换其他公司
BOSTON BEER CO INC的季度营收约是Ascendis Pharma A/S的1.7倍（$461.6M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs -4.1%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs -10.7%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
波士顿啤酒公司是美国知名酿酒企业，1984年由吉姆·科赫与朗达·卡尔曼联合创立。旗下首款产品以美国开国元勋、独立运动先驱塞缪尔·亚当斯命名，后续陆续推出多个自有品牌，2019年正式完成与角鲨头酿酒厂的合并，是北美精酿啤酒行业的核心参与者之一。
ASND vs SAM — 直观对比
营收规模更大
SAM
是对方的1.7倍
$267.3M
营收增速更快
ASND
高出46.4%
-4.1%
两年增速更快
ASND
近两年复合增速
-10.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $461.6M |
| 净利润 | — | — |
| 毛利率 | 90.5% | 46.4% |
| 营业利润率 | — | 12.4% |
| 净利率 | — | — |
| 营收同比 | 42.3% | -4.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $2.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDSAM
| Q1 26 | — | $461.6M | ||
| Q4 25 | $267.3M | $385.7M | ||
| Q3 25 | $230.7M | $537.5M | ||
| Q2 25 | $170.7M | $587.9M | ||
| Q1 25 | $109.0M | $453.9M | ||
| Q4 24 | $187.8M | $402.3M | ||
| Q3 24 | $62.5M | $605.5M | ||
| Q2 24 | $38.9M | $579.1M |
净利润ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | — | $-22.5M | ||
| Q3 25 | $-65.9M | $46.2M | ||
| Q2 25 | $-42.0M | $60.4M | ||
| Q1 25 | $-102.2M | $24.4M | ||
| Q4 24 | — | $-38.8M | ||
| Q3 24 | $-107.1M | $33.5M | ||
| Q2 24 | $-118.1M | $52.3M |
毛利率ASNDSAM
| Q1 26 | — | 46.4% | ||
| Q4 25 | 90.5% | 43.5% | ||
| Q3 25 | 89.5% | 50.8% | ||
| Q2 25 | 80.1% | 49.8% | ||
| Q1 25 | 82.6% | 48.3% | ||
| Q4 24 | 91.9% | 39.9% | ||
| Q3 24 | 80.6% | 46.3% | ||
| Q2 24 | 68.2% | 46.0% |
营业利润率ASNDSAM
| Q1 26 | — | 12.4% | ||
| Q4 25 | — | -8.6% | ||
| Q3 25 | 5.1% | 11.5% | ||
| Q2 25 | -33.5% | 14.0% | ||
| Q1 25 | -103.2% | 7.4% | ||
| Q4 24 | — | -13.9% | ||
| Q3 24 | -167.3% | 7.6% | ||
| Q2 24 | -370.2% | 12.2% |
净利率ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | — | -5.8% | ||
| Q3 25 | -28.5% | 8.6% | ||
| Q2 25 | -24.6% | 10.3% | ||
| Q1 25 | -93.7% | 5.4% | ||
| Q4 24 | — | -9.6% | ||
| Q3 24 | -171.5% | 5.5% | ||
| Q2 24 | -303.9% | 9.0% |
每股收益（稀释后）ASNDSAM
| Q1 26 | — | $2.16 | ||
| Q4 25 | — | $-1.97 | ||
| Q3 25 | — | $4.25 | ||
| Q2 25 | — | $5.45 | ||
| Q1 25 | — | $2.16 | ||
| Q4 24 | — | $-3.23 | ||
| Q3 24 | — | $2.86 | ||
| Q2 24 | — | $4.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $164.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $682.6M |
| 总资产 | $1.4B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDSAM
| Q1 26 | — | $164.1M | ||
| Q4 25 | $665.3M | $223.4M | ||
| Q3 25 | $582.2M | $250.5M | ||
| Q2 25 | $533.6M | $212.4M | ||
| Q1 25 | $559.4M | $152.5M | ||
| Q4 24 | $604.3M | $211.8M | ||
| Q3 24 | $675.6M | $255.6M | ||
| Q2 24 | $279.4M | $219.3M |
股东权益ASNDSAM
| Q1 26 | — | $682.6M | ||
| Q4 25 | $-175.8M | $846.3M | ||
| Q3 25 | $-188.0M | $911.0M | ||
| Q2 25 | $-202.6M | $912.3M | ||
| Q1 25 | $-205.0M | $897.0M | ||
| Q4 24 | $-114.2M | $916.2M | ||
| Q3 24 | $-105.1M | $1.0B | ||
| Q2 24 | $-346.8M | $1.0B |
总资产ASNDSAM
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.2B | $1.4B | ||
| Q2 24 | $819.0M | $1.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $39.9M | ||
| Q3 25 | — | $101.8M | ||
| Q2 25 | — | $126.5M | ||
| Q1 25 | $-15.5M | $1.9M | ||
| Q4 24 | $-330.7M | $41.9M | ||
| Q3 24 | — | $115.9M | ||
| Q2 24 | — | $96.0M |
自由现金流ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | — | $22.1M | ||
| Q3 25 | — | $89.2M | ||
| Q2 25 | — | $112.2M | ||
| Q1 25 | — | $-8.0M | ||
| Q4 24 | — | $18.4M | ||
| Q3 24 | — | $99.2M | ||
| Q2 24 | — | $75.6M |
自由现金流率ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 16.6% | ||
| Q2 25 | — | 19.1% | ||
| Q1 25 | — | -1.8% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 16.4% | ||
| Q2 24 | — | 13.1% |
资本支出强度ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 3.5% |
现金转化率ASNDSAM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.21× | ||
| Q2 25 | — | 2.09× | ||
| Q1 25 | — | 0.08× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.46× | ||
| Q2 24 | — | 1.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
